What research has been published on Retatrutide
Common side effects tend to be mild and go away the longer you are on the medication
However, initiating this therapy requires a thoughtful discussion with your healthcare provider
The resulting influx of Ca2+ causes vesicular exocytosis of GLP-1-containing vesicles
What to monitor: The same factors as the 1 mg phase, plus blood glucose patterns if you monitor them, hydration status (GLP-1 agonists can reduce thirst cues), and mood or energy shifts that may indicate metabolic transition
Retatrutide efficacy The phase 3 randomised, doubleblind, placebocontrolled TRIUMPH-1 trial evaluated the safety and efficacy of retatrutide for the treatment of patients with obesity or overweight, moderate-to-severe obstructive sleep apnoea and obesity, and knee osteoarthritis pain